Alembic Pharmaceuticals receives US FDA tentative approval for Dronedarone tablets
Dronedarone is indicated to reduce the risk of hospitalisation for atrial fibrillation in patients in sinus rhythm with a history…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AbbVie submits applications for Upadacitinib in to US FDA and EMA
In the trial study, evaluating the efficacy and safety of Upadacitinib in adult patients with nr-axSpA, Upadacitinib met its…
Exscientia and Sanofi establish research collaboration to develop AI-driven precision engineered…
Exscientia will receive an upfront cash payment of $100 million from Sanofi and will be eligible to receive future research,…
India to become hub for COVID-19 antiviral generic drugs: Fitch
Increased access to Molnupiravir will keep hospitalisations and deaths in India to a manageable level as Omicron infections rise,…
Covaxin booster dose study shows promising results
The phase-II, double-blind, randomised controlled Covaxin trial demonstrated long-term safety with no serious adverse events
We are in a better shape to handle any untoward circumstances
Ravi Udaya Bhaskar, Director-General, Pharmexcil, shares the scenario of pharma imports and exports, and the role played by…
People may need another COVID-19 vaccine booster shot in fall of 2022: Moderna CEO
Moderna, which benefits by repeat inoculations, during its third quarter earnings results said that commercial booster market…
J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
MSN to launch generic anti-COVID pill Molnupiravir under ‘Molulow’ brand
Molulow will come as a pack of 4×10 capsule strips with each capsule in 200 mg strength
Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
About 180 million Covaxin doses have been administered in India and more than three million doses have been exported or donated